Suppr超能文献

高分辨率测压亚型作为贲门失弛缓症治疗的预测因素:一项荟萃分析与系统评价

High-resolution manometric subtypes as a predictive factor for the treatment of achalasia: A meta-analysis and systematic review.

作者信息

Ou Ying Hua, Nie Xi Ming, Li Li Fu, Wei Zheng Jie, Jiang Bo

机构信息

Guangdong Provincial Key Laboratory of Gastroenterology, Department of Gastroenterology, Nanfang Hospital, Southern Medical University.

Department of Neurology, Beijing Tiantan Hospital, Capital Medical University.

出版信息

J Dig Dis. 2016 Apr;17(4):222-35. doi: 10.1111/1751-2980.12327.

Abstract

OBJECTIVE

To assess manometric subtypes as predictive factors for the treatment efficacies of pneumatic balloon dilatation (PBD) and laparoscopic Heller myotomy (LHM) in patients with achalasia.

METHODS

A systematic search of the Pubmed, Embase and Cochrane Library database was conducted to identify relevant publications on high-resolution manometric subtypes and different therapies for achalasia with predefined inclusion and exclusion criteria. Data on the success rates after PBD or LHM for different manometric subtypes were extracted. The pooled odds ratio (OR) and 95% confidence interval (CI) for different manometric subtypes were estimated using STATA 13.0.

RESULTS

In all, nine studies met the inclusion criteria. A total of 298 patients having achalasia receiving PBD and 429 undergoing LHM were included in the meta-analysis. The pooled OR between the subtypes of achalasia after PBD or LHM showed that the best and worse treatment outcomes were found in patients with type II and III achalasia, respectively (type I vs type II after PBD: OR 0.16, 95% CI 0.08-0.36, P = 0.000; type I vs type III after PBD: OR 3.64, 95% CI 1.55-8.53, P = 0.003; type II vs type III after PBD: OR 27.18, 95% CI 9.08-81.35, P = 0.000; type I vs type II after LHM: OR 0.26, 95% CI 0.12-0.56, P = 0.001; type I vs type III after LHM: OR 1.89, 95% CI 0.80-4.50, P = 0.148; type II vs type III after LHM: OR 6.86, 95% CI 2.72-17.28, P = 0.000).

CONCLUSION

Type II achalasia shows the best prognosis after PBD and LHM, while type III achalasia has the worst prognosis.

摘要

目的

评估测压亚型作为贲门失弛缓症患者气囊扩张术(PBD)和腹腔镜下Heller肌切开术(LHM)治疗效果的预测因素。

方法

对PubMed、Embase和Cochrane图书馆数据库进行系统检索,以确定关于高分辨率测压亚型和贲门失弛缓症不同治疗方法的相关出版物,并制定了预定义的纳入和排除标准。提取了不同测压亚型患者接受PBD或LHM后的成功率数据。使用STATA 13.0估计不同测压亚型的合并比值比(OR)和95%置信区间(CI)。

结果

共有9项研究符合纳入标准。荟萃分析纳入了298例接受PBD的贲门失弛缓症患者和429例接受LHM的患者。PBD或LHM后贲门失弛缓症亚型之间的合并OR显示,II型和III型贲门失弛缓症患者的治疗效果分别最佳和最差(PBD后I型与II型:OR 0.16,95%CI 0.08 - 0.36,P = 0.000;PBD后I型与III型:OR 3.64,95%CI 1.55 - 8.53,P = 0.003;PBD后II型与III型:OR 27.18,95%CI 9.08 - 81.35,P = 0.000;LHM后I型与II型:OR 0.26,95%CI 0.12 - 0.56,P = 0.001;LHM后I型与III型:OR 1.89,95%CI 0.80 - 4.50,P = 0.148;LHM后II型与III型:OR 6.86,95%CI 2.72 - 17.28,P = 0.000)。

结论

II型贲门失弛缓症在PBD和LHM后预后最佳,而III型贲门失弛缓症预后最差。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验